EdiGENE Raises $15 Million in Series B Funding
TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 10, 2019--EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announ…
TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 10, 2019--EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announ…